MIRA INFORM REPORT
|
Report Date : |
13.04.2011 |
IDENTIFICATION DETAILS
|
Name : |
BIOMAX BIOTECHNICS PRIVATE LIMITED |
|
|
|
|
Registered Office : |
SCO 867, Basement, NAC, Manimajra, Chandigarh-160101 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
13.08.2009 |
|
|
|
|
Com. Reg. No.: |
53-031718 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24100CH2009PTC031718 |
|
|
|
|
TIN : |
04620023121 |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AADCB8274H |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of Formulations such as tablets, injections and new drugs |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 40400 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track. Trade
Relations are reported as fair. Business is active. Payments are reported to
be slow but correct. The company can be considered for business dealings at usual trade
terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Ms. Minakshi |
|
Designation : |
Account Department |
|
Date : |
25.03.2011 |
LOCATIONS
|
Registered Office/ Factory : |
SCO 867, Basement, NAC, Manimajra, Chandigarh-160101, |
|
Tel. No.: |
91-172-4245666 / 5035829 / 5035834 / 4245666 / 4245610 |
|
Mobile No.: |
91-9316523497 (Mr. Ramesh) |
|
Fax No.: |
91-172-4629655 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Rented |
DIRECTORS
As on 30.09.2010
|
Name : |
Mr. Kamaljeet Singh |
|
Designation : |
Director |
|
Address : |
House No. 274, Ward No. 6, Shahbad, Tehsil-Shahbad,
District-Kurukshetra, Kurukshetra-136135, |
|
Date of Birth/Age : |
08.08.1970 |
|
Date of Appointment : |
13.08.2009 |
|
DIN : |
02721985 |
|
|
|
|
Name : |
Mr. Gurdayal Singh |
|
Designation : |
Director |
|
Address : |
House No. 274, Ward No. 6, Shahbad, Tehsil-Shahbad,
District-Kurukshetra, Kurukshetra-136135, |
|
Date of Birth/Age : |
01.02.1946 |
|
Date of Appointment : |
13.08.2009 |
|
Date of Ceasing : |
25.08.2010 |
|
|
|
|
Name : |
Mr. Jagjit Singh |
|
Designation : |
Director |
|
Address : |
House No. 274, Ward No. 6, Shahbad, Tehsil-Shahbad,
District-Kurukshetra, Kurukshetra-136135, |
|
Date of Birth/Age : |
22.11.1971 |
|
Date of Appointment : |
25.08.2010 |
|
DIN : |
02600110 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Mr. Kamaljeet Singh |
|
345000 |
|
Mr. Jagjit Singh |
|
5000 |
|
Total |
|
350000 |
As on 30.09.2010
|
Category |
Percentage |
|
|
|
|
Directors or relatives of Directors |
100.00 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Formulations such as tablets, injections and new drugs |
|
|
|
|
Products : |
|
|
|
|
|
Terms : |
|
|
Selling : |
Depend |
|
|
|
|
Purchasing : |
Depend |
GENERAL INFORMATION
|
Customers : |
Wholesalers, End Users and OEM’s |
||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
|
No. of Employees : |
20 (Approximately) |
||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
|
Bankers : |
Ř
Kotak Mahindra Bank Ř
HDFC Bank Ř
ICICI Bank, NAC, Manimajra Branch,
Chandigarh-160101, Ř
Allahabad Bank, SCO 12-A, Sector 11, Panchkula –
134109, |
||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||||||||||||||
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Sushil K. Singla and Company Chartered Accountants |
|
Address : |
House No.1709, Sector 22-B, |
|
PAN No. : |
AAZFS8645J |
|
|
|
|
Related Party : |
Acekinetics Healthcare Limited |
CAPITAL STRUCTURE
As on 30.09.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
500,000 |
Equity Shares |
Rs. 10/- each |
Rs.5.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
350,000 |
Equity Shares |
Rs. 10/-
each |
Rs.3.500
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
|
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
|
3.500 |
|
|
2] Share Application Money |
|
|
0.000 |
|
|
3] Reserves & Surplus |
|
|
1.228 |
|
|
4] (Accumulated Losses) |
|
|
0.000 |
|
|
NETWORTH |
|
|
4.728 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
|
4.540 |
|
|
2] Unsecured Loans |
|
|
5.563 |
|
|
TOTAL BORROWING |
|
|
10.103 |
|
|
DEFERRED TAX LIABILITIES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
14.831 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
5.360 |
|
|
Capital work-in-progress |
|
|
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
|
0.000 |
|
|
DEFERREX TAX ASSETS |
|
|
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
|
19.705 |
|
|
Sundry Debtors |
|
|
8.451 |
|
|
Cash & Bank Balances |
|
|
3.064 |
|
|
Other Current Assets |
|
|
0.800 |
|
|
Loans & Advances |
|
|
0.672 |
|
Total
Current Assets |
|
|
32.692 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
|
21.175 |
|
|
Other Current Liabilities |
|
|
1.046 |
|
|
Provisions |
|
|
1.108 |
|
Total
Current Liabilities |
|
|
23.329 |
|
|
Net Current Assets |
|
|
9.363 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
|
0.108 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
14.831 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
|
|
31.03.2010 |
|
|
SALES |
|
|
|
|
|
Income |
|
|
52.522 |
|
|
Other Income |
|
|
0.008 |
|
|
TOTAL (A) |
|
|
52.530 |
|
|
|
|
|
|
|
Less |
EXPENSES
(B) |
|
|
49.404 |
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
|
|
3.118 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
|
|
0.647 |
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
|
|
2471 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
|
|
0.694 |
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
|
|
1.777 |
|
|
|
|
|
|
|
Less |
TAX (I) |
|
|
0.549 |
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
|
|
1.228 |
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
|
|
1.228 |
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
|
|
|
Expected Sales (2010-2011) : Rs. 90.000 Millions.
KEY RATIOS
|
PARTICULARS |
|
|
|
31.03.2010 |
|
PAT / Total Income |
(%) |
|
|
2.34 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
|
|
3.38 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
|
|
4.67 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
|
|
0.18 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
|
|
3.31 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
|
|
1.40 |
LOCAL AGENCY FURTHER INFORMATION
Trade References :
Ř
Gujral Formulations
Operations :
Total income during the 2009-2010 aggregated to Rs. 52.530 million and pre
tax profit amounted to Rs. 1.777. The performance of the company during the
year was satisfactory.
Bankers Charges
Report as per Registry
|
Corporate
identity number of the company |
U24100CH2009PTC031718 |
|
Name of the
company |
BIOMAX BIOTECHNICS
PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
S.C.O. 867,
Basement, Nac, Manimajra |
|
This form is for |
Creation of charge |
|
Type of charge |
Ř Book Debts Ř Movable Property |
|
Particular of
charge holder |
Allahabad Bank, SCO 12-A, Sector 11, Panchkula – 134109, Email : csvirender82@gmail.com |
|
Nature of
instrument creating charge |
Hypothecation
Agreement Dated 11.03.2010. |
|
Date of
instrument Creating the charge |
11.03.2010 |
|
Amount secured by
the charge |
Rs.2.000 million |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of Interest
- PLR, Presently 12% Terms of
Repayment - On Demand Margin - 25% Extent and
Operation of the charge – 100% |
|
Short particulars
of the property or asset(s) charged (including complete address and location
of the property) |
First charge on
all the present and future products, goods and movable property of any kind
of the company as per hypothecation
agreement dated 11.03.2010. |
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.20 |
|
|
1 |
Rs.72.26 |
|
Euro |
1 |
Rs.63.90 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
29 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.